Mirum Pharmaceuticals, Inc. (MIRM)
82.06
+1.92
(+2.40%)
USD |
NASDAQ |
Oct 19, 13:19
Mirum Pharmaceuticals Cash from Operations (Annual) : 55.83M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 55.83M |
| December 31, 2024 | 10.32M |
| December 31, 2023 | -70.94M |
| December 31, 2022 | -120.14M |
| Date | Value |
|---|---|
| December 31, 2021 | -132.76M |
| December 31, 2020 | -89.08M |
| December 31, 2019 | -39.36M |
| December 31, 2018 | -0.373M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Incyte Corp. | 1.413B |
| Insmed, Inc. | -935.01M |
| Galectin Therapeutics, Inc. | -23.88M |
| Kodiak Sciences, Inc. | -136.01M |
| Praxis Precision Medicines, Inc. | -249.07M |